Ulubay Gaye, Ulasli Sevinc, Küpeli Elif, Yilmaz Eylul, Sezgin Atilla, Haberal Mehmet
Department of Pulmonary Diseases, Baskent University School of Medicine, Ankara, Turkey.
Ann Transplant. 2010 Apr-Jun;15(2):11-20.
The pre-operative pulmonary risk assessment of solid organ transplant recipients is crucial to decrease post-operative pulmonary mortality and morbidity. Spirometry is the most commonly utilized test to predict post-operative pulmonary complications. This study was performed to evaluate the role of Cardiopulmonary Exercise Testing (CPET) in both heart and kidney transplantation recipients.
MATERIAL/METHODS: Patients referred for pulmonary evaluation between August 2008 and June 2009 prior to solid organ transplantation were included in this study. Patients' history, demographics, and physical examination were recorded. All patients performed pulmonary function tests (PFTs) and symptom-limited CPET. Thirty-four subjects (21 with heart failure and 16 with chronic renal failure) awaiting solid organ transplantation were enrolled to this study prospectively.
No pulmonary complication was found in the renal transplantation recipients, and there were pulmonary complications in 10 heart transplantation recipients. There was no difference between spirometric parameters with post-operative early pulmonary complications and mortality (p>0.05) in heart and kidney transplantation recipients. Anaerobic threshold oxygen uptake (VO(2)@AT) was significantly decreased, while minute ventilation to carbon dioxide output (VE/VCO(2)@AT) was increased in heart recipients (p<0.05).
CPET parameters measured at anaerobic threshold could help predict surgical mortality and pulmonary complications following heart transplantation. However, our study demonstrated that CPET parameters could not predict post-operative mortality and pulmonary complications in renal recipients. Therefore, heart transplant candidates should be routinely evaluated with CPET and spirometry to estimate post-operative early mortality and pulmonary complications pre-operatively.
实体器官移植受者的术前肺部风险评估对于降低术后肺部死亡率和发病率至关重要。肺活量测定是预测术后肺部并发症最常用的检查方法。本研究旨在评估心肺运动试验(CPET)在心脏和肾脏移植受者中的作用。
材料/方法:本研究纳入了2008年8月至2009年6月期间在实体器官移植前接受肺部评估的患者。记录患者的病史、人口统计学资料和体格检查结果。所有患者均进行了肺功能测试(PFTs)和症状限制性CPET。前瞻性纳入了34名等待实体器官移植的受试者(21名心力衰竭患者和16名慢性肾衰竭患者)。
肾移植受者未发现肺部并发症,10名心脏移植受者出现了肺部并发症。心脏和肾脏移植受者的肺活量测定参数与术后早期肺部并发症和死亡率之间无差异(p>0.05)。心脏移植受者的无氧阈摄氧量(VO(2)@AT)显著降低,而分钟通气量与二氧化碳排出量之比(VE/VCO(2)@AT)升高(p<0.05)。
无氧阈时测量的CPET参数有助于预测心脏移植后的手术死亡率和肺部并发症。然而,我们的研究表明CPET参数不能预测肾移植受者的术后死亡率和肺部并发症。因此,心脏移植候选者应常规进行CPET和肺活量测定评估,以术前估计术后早期死亡率和肺部并发症。